Last Price
0.013
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Profile
HXL
Exchange: Australian Securities Exchange Australian Securities Exchange
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Geoffrey Paul Kempler Geoffrey Paul Kempler
Full Time Employees: 0 0
IPO Date: 2020-11-30 2020-11-30
ISIN: AU0000111932 AU0000111932
Beta: 0.85 0.85
Last Dividend: 0.00 0.00
Dcf Diff: -0.00 -0.00
Dcf: 0.01 0.01
Description
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.
Address
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Oxford Innotech Berhad, a precision engineering and automation solutions provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1208/Thumbnail_.png)
![[New IPO] Enproserve Group Berhad, a plant maintenance specialist in the O&G sector, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1198/Thumbnail__(10).png)
Apps
Top Articles
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now